<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00524511</url>
  </required_header>
  <id_info>
    <org_study_id>12462</org_study_id>
    <nct_id>NCT00524511</nct_id>
  </id_info>
  <brief_title>Comparison Study of Wound Closure at Time of Cesarean Delivery: Dermabond Glue Versus Surgical Staples</brief_title>
  <official_title>A Comparative Study of Closure Techniques After Cesarean Section: Staples vs. Dermabond</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Massachusetts, Worcester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Massachusetts, Worcester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women who have a cesarean delivery have a surgical incision on their abdomen (belly). The
      usual way to close this opening is with metal surgical staples. In many other types of
      surgery, surgical incisions are closed with a super-glue called Dermabond. The researchers at
      the University of Massachusetts believe Dermabond may be a safe alternative to using staples
      at the time of a cesarean delivery, but this has not been studied. Women who choose to
      participate will be randomly assigned to have the cesarean delivery skin incision closed with
      staples or Dermabond. The researchers will survey the patients to see how they felt about the
      experience and the appearance of their scar. The researchers will survey physicians
      performing the surgery to see how easy Dermabond was to use. The researchers will ask
      physicians to evaluate the appearance of the incision after a 6-week recovery period and will
      analyze complications (such as bruising, infection, or separation of the wound) in the two
      groups.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor enrollment, much data was missing as patients were lost to follow up
  </why_stopped>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound Complication Rate</measure>
    <time_frame>within six weeks of study intervention</time_frame>
    <description>Wound seroma or hematoma, wound separation, wound requiring packing, cellulitis, required extra medical clinic visits to evaluate wound</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction of Cosmesis of Surgical Wound</measure>
    <time_frame>before hospital discharge after surgery</time_frame>
    <description>survey questionnaire using a visual analog scale to inquire about incision appearance, satisfaction with method of closure and comparison to previous closure type (if applicable)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">136</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women receiving Dermabond for skin closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women receiving standard surgical skin staples</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Surgical skin staples</intervention_name>
    <description>Standard method to close abdominal surgical wounds</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dermabond</intervention_name>
    <description>Alternative method (superglue) to close abdominal surgical wounds</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Tissue adhesive</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women undergoing scheduled and non-scheduled cesarean deliveries

        Exclusion Criteria:

          -  Prisoners

          -  Insulin-requiring diabetics

          -  Vertical skin incision

          -  Allergy to Dermabond
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dawn S Tasillo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Massachusetts, Worcester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UMass Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2007</study_first_submitted>
  <study_first_submitted_qc>August 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2007</study_first_posted>
  <results_first_submitted>October 24, 2012</results_first_submitted>
  <results_first_submitted_qc>January 24, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 5, 2013</results_first_posted>
  <last_update_submitted>January 24, 2013</last_update_submitted>
  <last_update_submitted_qc>January 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Massachusetts, Worcester</investigator_affiliation>
    <investigator_full_name>Dawn Tasillo</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>cesarean</keyword>
  <keyword>wound</keyword>
  <keyword>Dermabond</keyword>
  <keyword>superglue</keyword>
  <keyword>staples</keyword>
  <keyword>wound complications</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>September 4, 2007-July 9, 2010 Recruitment occured in the medical clinics and Labor and Delivery unit of an academic medical center</recruitment_details>
      <pre_assignment_details>The study design dictates that patients be enrolled upon admission to Labor and Delivery. Subsequently, patients who did not deliver by cesarean delivery would be excluded</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Group Receiving Alternative Skin Closure Method (Dermabond)</title>
          <description>Women receiving Dermabond for skin closure</description>
        </group>
        <group group_id="P2">
          <title>Group Receiving Standard Skin Closure Method (Surgical Staples</title>
          <description>Women receiving standard surgical skin staples</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
                <participants group_id="P2" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group Receiving Alternative Skin Closure Method (Dermabond)</title>
          <description>Women receiving Dermabond for skin closure</description>
        </group>
        <group group_id="B2">
          <title>Group Receiving Standard Skin Closure Method (Surgical Staples</title>
          <description>Women receiving standard surgical skin staples</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="68"/>
            <count group_id="B2" value="68"/>
            <count group_id="B3" value="136"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Wound Complication Rate</title>
        <description>Wound seroma or hematoma, wound separation, wound requiring packing, cellulitis, required extra medical clinic visits to evaluate wound</description>
        <time_frame>within six weeks of study intervention</time_frame>
        <population>No participants were analyzed due to poor enrollment, subjects lost to follow-up and incomplete/partial data.</population>
        <group_list>
          <group group_id="O1">
            <title>Group Receiving Alternative Skin Closure Method (Dermabond)</title>
            <description>Women receiving Dermabond for skin closure</description>
          </group>
          <group group_id="O2">
            <title>Group Receiving Standard Skin Closure Method (Surgical Staples</title>
            <description>Women receiving standard surgical skin staples</description>
          </group>
        </group_list>
        <measure>
          <title>Wound Complication Rate</title>
          <description>Wound seroma or hematoma, wound separation, wound requiring packing, cellulitis, required extra medical clinic visits to evaluate wound</description>
          <population>No participants were analyzed due to poor enrollment, subjects lost to follow-up and incomplete/partial data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction of Cosmesis of Surgical Wound</title>
        <description>survey questionnaire using a visual analog scale to inquire about incision appearance, satisfaction with method of closure and comparison to previous closure type (if applicable)</description>
        <time_frame>before hospital discharge after surgery</time_frame>
        <population>No participants were analyzed due to poor enrollment, subjects lost to follow-up and incomplete/partial data.</population>
        <group_list>
          <group group_id="O1">
            <title>Group Receiving Alternative Skin Closure Method (Dermabond)</title>
            <description>Women receiving Dermabond for skin closure</description>
          </group>
          <group group_id="O2">
            <title>Group Receiving Standard Skin Closure Method (Surgical Staples</title>
            <description>Women receiving standard surgical skin staples</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction of Cosmesis of Surgical Wound</title>
          <description>survey questionnaire using a visual analog scale to inquire about incision appearance, satisfaction with method of closure and comparison to previous closure type (if applicable)</description>
          <population>No participants were analyzed due to poor enrollment, subjects lost to follow-up and incomplete/partial data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Group Receiving Alternative Skin Closure Method (Dermabond)</title>
          <description>Women receiving Dermabond for skin closure</description>
        </group>
        <group group_id="E2">
          <title>Group Receiving Standard Skin Closure Method (Surgical Staples</title>
          <description>Women receiving standard surgical skin staples</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dawn Tasillo, MD</name_or_title>
      <organization>UMass Memorial Medical Center</organization>
      <phone>5083346255</phone>
      <email>tasillod@ummhc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

